Publications by authors named "Chang-Ching A Lin"

Claim this Profile
C
CD8+ T cells in the tumor microenvironment modulate response to endocrine therapy in breast cancer.
Fabiana Napolitano, Yunguan Wang, Dhivya R Sudhan, Paula I Gonzalez-Ericsson, Luigi Formisano, Chang-Ching A Lin, Lin Xu

J Clin Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations" [619 1 (2025) 217668 1-13].
Yasuaki Uemoto, Chang-Ching A Lin, Bingnan Wang, Dan Ye, Yisheng V Fang

Cancer Lett· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations.
Yasuaki Uemoto, Chang-Ching A Lin, Bingnan Wang, Dan Ye, Yisheng V Fang

Cancer Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.
Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni, Ellen Jaeger, Yisheng V Fang, Lin Xu

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis